Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial. - Wikidata - awgldk - TriplyDB

Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.

Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.

http://www.wikidata.org/entity/Q36763152

about

Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial.Serum fibroblast growth factor 21 levels are correlated with the severity of diabetic retinopathy.The Role of Systemic Risk Factors in Diabetic Retinopathy Expression of wild-type p53-induced phosphatase 1 in diabetic epiretinal membranes.Diabetic retinopathy risk factors: plasma erythropoietin as a risk factor for proliferative diabetic retinopathy.C-reactive protein and chitinase 3-like protein 1 as biomarkers of spatial redistribution of retinal blood vessels on digital retinal photography in patients with diabetic retinopathy.C-reactive protein genetic variant is associated with diabetic retinopathy in Chinese patients with type 2 diabetes P-selectin Plasma Levels and Genetic Variant Associated With Diabetic Retinopathy in African Americans.Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes.Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?The Diabetes Visual Function Supplement Study (DiVFuSS)C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes.TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy The evolving treatment options for diabetic macular edema.Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.Aqueous humor pentraxin-3 levels in patients with diabetes mellitus.Evaluation of biochemical and clinical markers of endothelial dysfunction and their correlation with urinary albumin excretion in patients with type 1 diabetes mellitus.Plasma neutrophil gelatinase-associated lipocalin levels are positively associated with diabetic retinopathy in patients with Type 2 diabetes.

P2860

Q31018013-31D1DBE6-89DB-4AF0-B124-137964DFC30C Q33563076-4B8538A5-6E29-43AE-A694-CF77403DEAE1 Q33689773-BD8EAD59-CA94-4DFB-A674-4AE2A2502CB4 Q33829214-6E8A22D3-9C47-4FA6-974E-D1C0D514DF1B Q34263212-E77B70A1-C1E7-429F-9087-36FE64366623 Q35099967-A8EDA2ED-6A79-4D5C-B9C7-34BF1C54DDE2 Q35151396-308CAB3D-889F-4CA8-8C74-31E4D051261B Q35589517-33D8EAB7-FF30-4A90-A31D-66461AF9456B Q35739097-C885EF06-09F0-4F76-8A3F-D0194749F1E9 Q35962884-40C83C41-4F8C-4FF8-8188-9F2529F6999C Q36384149-831C414B-2A76-4205-AAF9-52B1238E000B Q36577211-AE0418A9-9E36-4227-BF1A-4C8D809BF123 Q36622467-B11E1DD7-9FC3-483D-9B42-3A8A40BEB9E6 Q37095335-A0832130-8090-40A2-8934-C0C2602E0688 Q37292151-0659A5F1-A2DA-4F04-9733-F899C6A1C2D5 Q38150855-103C26D4-B925-4F27-9CFD-BA5629D6A335 Q38682902-26114C6A-4362-49D7-8785-DA6FCA06A477 Q50962850-5AEFFA5F-DB8A-407A-B3A4-6D0B2CCCBFF1 Q52884442-AAE7C42F-0F12-4C66-B2F4-4661DEF3904D Q53161994-ED7142BF-C0B0-4339-8F51-DDD49A44E16A

P2860

Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.

http://www.wikidata.org/entity/Q36763152

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Prospective study of inflammat ...... ntrol and complications trial.

@ast

Prospective study of inflammat ...... ntrol and complications trial.

@en

type

label

Prospective study of inflammat ...... ntrol and complications trial.

@ast

Prospective study of inflammat ...... ntrol and complications trial.

@en

prefLabel

Prospective study of inflammat ...... ntrol and complications trial.

@ast

Prospective study of inflammat ...... ntrol and complications trial.

@en

P1433

Q36763152-3316CDE0-D6E9-4DF0-B30D-9AC2CC5CC405

P1476

Q36763152-359A21A3-796B-4F97-B5AB-8C62DADAE9EA

P2093

Q36763152-56AAE81D-C50A-418F-ACDE-8BC346CBE600

Q36763152-7D4A9FBE-A639-4CDD-BA37-8C515C2888CF

Q36763152-C00D06CD-C7AE-4FAE-9E81-04E2675654B8

Q36763152-C5D28018-6CB7-4F21-B191-9F74BFB54E3D

Q36763152-DC074E30-3A90-4DE7-BB3C-9873DF1C2193

P2860

Q36763152-1B089E62-9EBE-4390-9C2B-7B7BB780205A

Q36763152-1C8E9BC7-609D-4308-9824-4F9B5DC699EA

Q36763152-3C4C8988-A411-4B72-BE53-DACBAE3AEB52

Q36763152-4484E691-7BF3-4FD5-BD39-575498EC1928

Q36763152-4831210D-876D-4D9F-8523-691B9D1AAF3D

Q36763152-537C1F5A-13EB-4BA4-947F-75FD3CBCE019

Q36763152-5760819D-0926-4718-B320-5E71D1D94A32

Q36763152-646E21CD-879F-4F54-AD97-C2A4C127D22E

Q36763152-68ADDCED-4854-43D4-9134-B60D01607CAD

Q36763152-6E09DCF1-CE9C-4FF4-9356-3B1F1B215D73

P304

Q36763152-D4B3A504-81FB-44A4-8AF4-9B4279FBE252

P31

Q36763152-19F171FF-4C86-4772-B04D-3444E2173362

P356

Q36763152-253F0771-93A3-4282-A229-02692C305245

P407

Q36763152-F8CF00ED-62E8-4D11-8FF2-59DF6C2F4ABF

P433

Q36763152-69CDCFD1-4E93-4262-AEAE-6082A2790EEE

P478

Q36763152-34F75E20-80CE-4D55-AC12-065BBA868374

P50

Q36763152-C0258B90-4EFE-4796-B7E7-B460111C4F05

P577

Q36763152-E81BE7B3-53E1-49CC-BD91-17298596FB92

P698

Q36763152-03597A61-C632-4142-BB86-6FAF511CA3C5

P921

Q36763152-96DE79C3-2D0C-4962-8C75-D8F6E002FD23

P932

Q36763152-9ECED3FB-6A08-4A44-8FE9-3FA075D6E0EB

P356

JAMAOPHTHALMOL.2013.2299

P1433

JAMA Ophthalmology

P1476

Prospective study of inflammat ...... ntrol and complications trial.

@en

P2093

Debra A Schaumberg

http://www.w3.org/2001/XMLSchema#string

Eudocia Q Lee

http://www.w3.org/2001/XMLSchema#string

JoAnn E Manson

http://www.w3.org/2001/XMLSchema#string

Radha P Kohly

http://www.w3.org/2001/XMLSchema#string

Rajeev H Muni

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Leukocyte-mediated endothelial cell injury and death in the diabetic retina

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial

Novel potential mechanisms for diabetic macular edema: leveraging new investigational approaches.

Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes.

Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.

Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.

Perspectives on diabetic retinopathy.

Inflammatory markers and retinopathy in pregnancies complicated with type I diabetes.

P304

514-521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAOPHTHALMOL.2013.2299

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

Richard D Semba

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23392399

http://www.w3.org/2001/XMLSchema#string

P921

P932

3625475

http://www.w3.org/2001/XMLSchema#string